JUBILANT PHARMOVA LIMITED revenue for the last year amounted to 62.82 B INR, the most of which — 25.52 B INR — came from its highest performing source at the moment, Radiopharma. The greatest contribution to the revenue figure was made by Americas and Europe — last year it brought JUBILANT PHARMOVA LIMITED 55.93 B INR, and the year before that — 53.19 B INR.